- Home
- LCFY vs INM Comparison
LCFY vs INM Comparison
Compare LCFY & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCFY
- INM
- Stock Information
- Founded
- LCFY 2009
- INM 1981
- Country
- LCFY Australia
- INM Canada
- Employees
- LCFY N/A
- INM N/A
- Industry
- LCFY
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- LCFY
- INM Health Care
- Exchange
- LCFY Nasdaq
- INM Nasdaq
- Market Cap
- LCFY 3.7M
- INM 3.2M
- IPO Year
- LCFY 2022
- INM N/A
- Fundamental
- Price
- LCFY $6.30
- INM $3.32
- Analyst Decision
- LCFY
- INM
- Analyst Count
- LCFY 0
- INM 0
- Target Price
- LCFY N/A
- INM N/A
- AVG Volume (30 Days)
- LCFY 4.9M
- INM 9.5M
- Earning Date
- LCFY 07-07-2025
- INM 05-12-2025
- Dividend Yield
- LCFY N/A
- INM N/A
- EPS Growth
- LCFY N/A
- INM N/A
- EPS
- LCFY N/A
- INM N/A
- Revenue
- LCFY $2,668,385.00
- INM $4,920,990.00
- Revenue This Year
- LCFY N/A
- INM N/A
- Revenue Next Year
- LCFY N/A
- INM N/A
- P/E Ratio
- LCFY N/A
- INM N/A
- Revenue Growth
- LCFY N/A
- INM N/A
- 52 Week Low
- LCFY $2.28
- INM $1.72
- 52 Week High
- LCFY $13.98
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- LCFY 63.49
- INM 59.24
- Support Level
- LCFY $2.51
- INM $2.26
- Resistance Level
- LCFY $13.98
- INM $5.50
- Average True Range (ATR)
- LCFY 0.91
- INM 0.40
- MACD
- LCFY 0.42
- INM 0.11
- Stochastic Oscillator
- LCFY 33.04
- INM 37.04
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.